Source: Annual Congress 2008 - High-risk patients for major lung cancer surgery



Rating:

Share or cite this content

Citations should be made in the following way:
J. Vansteenkiste (Leuven, Belgium). Multimodality lung cancer therapy – nonsurgical complications. Annual Congress 2008 - High-risk patients for major lung cancer surgery

Member's Comments

No comment yet.

Related content which might interest you: Nonsurgical treatment of recurrent lung cancer Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent Year: 2007 Postoperative lung cancer relapse after chemoradiation therapy Source: International Congress 2014 – Thoracic oncology grand round - an interactive session Year: 2014 Successful targeted therapy of advanced lung cancer Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session Year: 2013 Early complications after lung resections at patients treated for lung cancer with and without neoadjuvant hemiotheraphy Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 Optimising treatment for post-operative lung cancer recurrence Source: Eur Respir J 2016; 47: 374-378 Year: 2016 Preoperative endobronchial photodynamic therapy improves surgical radicalism for locally advanced NSCLC Source: Annual Congress 2012 - From the laser through the stent to the valve: the broad spectrum of interventional pneumology Year: 2012 Surgical and nonsurgical approaches to small-size nonsmall cell lung cancer Source: Eur Respir J 2014; 44: 483-494 Year: 2014 Surgical treatment of locally recurrent lung cancer Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent Year: 2007 Combined and organ-saving operations in patients with advanced lung cancer after induction chemotherapy Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010 Preoperative pulmonary complication risk assessment in patients undergoing curative surgery for lung cancer Source: International Congress 2017 – Thoracic surgery Year: 2017 Perioperative systemic therapy in resectable lung cancer: from standard operating procedures to immuno-oncology and back Source: Virtual Congress 2020 – Thoracic oncology Year: 2020 Surgical treatment of lung cancer after polyhemothetapy/radiotherapy down-staging in patients initially assessed as inoperable Source: Eur Respir J 2006; 28: Suppl. 50, 718s Year: 2006 Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Possibilities of palliative combined therapy for extensive nonsmall cells lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 378s Year: 2001 Impact of neoadjuvant therapies on surgical indications and early postoperative outcome Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts Year: 2005 Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer? Source: Eur Respir J 2003; 22: 535-541 Year: 2003